2020-06-17 REL RCSB RCSB RCSB 2020-03-04 2020-05-13 2020-05-13 2020-06-17 National Institutes of Health/Office of the Director DP2EB020402 United States National Institutes of Health/Office of the Director S10OD021634 United States National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) R35GM134867 United States Hirschi M Santiago-Frangos A Wilkinson R Golden SM Wiedenheft B Lander GC Hirschi M Lu WT Santiago-Frangos A Wilkinson R Golden SM Davidson AR Lander GC Wiedenheft B Nat Commun UK 11 2730 2730 2020 32483187 doi:10.1038/s41467-020-16512-1 2041-1723 EMD-21516 other EM volume EMD-21517 associated EM volume 6whi FULLOVERLAP Anti-CRISPR AcrIF9 bound to the type I-F crRNA-guided CRISPR surveillance complex Anti-CRISPR AcrIF9 bound to the type I-F crRNA-guided CRISPR surveillance complex 0 1 2 3 4 5 6 7 8 type I-F crRNA-guided CRISPR surveillance complex 1 1 2 3 4 5 7 8 Pseudomonas aeruginosa Escherichia coli Anti-CRISPR AcrIF9 1 6 Proteus penneri Escherichia coli CRISPR-associated protein Csy1 Pseudomonas aeruginosa Escherichia coli LEVO MTSPLPTPTWQELRQFIESFIQERLQGKLDKLQPDEDDKRQTLLATHRREAWLADAARRVGQLQLVTHTLKPIHPDARGS NLHSLPQAPGQPGLAGSHELGDRLVSDVVGNAAALDVFKFLSLQYQGKNLLNWLTEDSAEALQALSDNAEQAREWRQAFI GITTVKGAPASHSLAKQLYFPLPGSGYHLLAPLFPTSLVHHVHALLREARFGDAAKAAREARSRQESWPHGFSEYPNLAI QKFGGTKPQNISQLNNERRGENWLLPSLPPNWQRQNVNAPMRHSSVFEHDFGRTPEVSRLTRTLQRFLAKTVHNNLAIRQ RRAQLVAQICDEALQYAARLRELEPGWSATPGCQLHDAEQLWLDPLRAQTDETFLQRRLRGDWPAEVGNRFANWLNRAVS SDSQILGSPEAAQWSQELSKELTMFKEILEDERD Type I-F CRISPR-associated protein Csy2 Pseudomonas aeruginosa LEVO MSVTDPEALLLLPRLSIQNANAISSPLTWGFPSPGAFTGFVHALQRRVGISLDIELDGVGIVCHRFEAQISQPAGKRTKV FNLTRNPLNRDGSTAAIVEEGRAHLEVSLLLGVHGDGLDDHPAQEIARQVQEQAGAMRLAGGSILPWCNERFPAPNAELL MLGGSDEQRRKNQRRLTRRLLPGFALVSREALLQQHLETLRTTLPEATTLDALLDLCRINFEPPATSSEEEASPPDAAWQ VRDKPGWLVPIPAGYNALSPLYLPGEVRNARDRETPLRFVENLFGLGEWLSPHRVAALSDLLWYHHAEPDKGLYRWSTPR FVEHAIA CRISPR-associated protein Csy3 Pseudomonas aeruginosa LEVO MKSSHHHHHHENLYFQSNASKPILSTASVLAFERKLDPSDALMSAGAWAQRDASQEWPAVTVREKSVRGTISNRLKTKDR DPAKLDASIQSPNLQTVDVANLPSDADTLKVRFTLRVLGGAGTPSACNDAAYRDKLLQTVATYVNDQGFAELARRYAHNL ANARFLWRNRVGAEAVEVRINHIRQGEVARAWRFDALAIGLRDFKADAELDALAELIASGLSGSGHVLLEVVAFARIGDG QEVFPSQELILDKGDKKGQKSKTLYSVRDAAAIHSQKIGNALRTIDTWYPDEDGLGPIAVEPYGSVTSQGKAYRQPKQKL DFYTLLDNWVLRDEAPAVEQQHYVIANLIRGGVFGEAEEK RNA (60-MER) Pseudomonas aeruginosa LEVO CUAAGAAAUUCACGGCGGGCUUGAUGUCCGCGUCUACCUGGUUCACUGCCGUAUAGGCAG CRISPR-associated endonuclease Cas6/Csy4 Pseudomonas aeruginosa LEVO MDHYLDIRLRPDPEFPPAQLMSVLFGKLHQALVAQGGDRIGVSFPDLDESRSRLGERLRIHASADDLRALLARPWLEGLR DHLQFGEPAVVPHPTPYRQVSRVQAKSNPERLRRRLMRRHDLSEEEARKRIPDTVARALDLPFVTLRSQSTGQHFRLFIR HGPLQVTAEEGGFTCYGLSKGGFVPWF anti-CRISPR AcrIF9 Proteus penneri LEVO MKSTYIIKEVQNINSDREGVKVETTSLTSAKRIASKNQFFHGTVLRIESESGNWLAYKEDGKRWIECE non-target dsDNA Pseudomonas aeruginosa LEVO (DG)(DC)(DA)(DG)(DC)(DT)(DC)(DG)(DA)(DG)(DT)(DT)(DA)(DA)(DG)(DA)(DC)(DG)(DG)(DT) (DA)(DT)(DT)(DG)(DT)(DT)(DC)(DA)(DG)(DA)(DT)(DC)(DC)(DT)(DG)(DG)(DC)(DT)(DT)(DG) (DC)(DC)(DA)(DA)(DC)(DA)(DG)(DT)(DG)(DA)(DT)(DT)(DT)(DG)(DC)(DT)(DC)(DA)(DT)(DT) (DT)(DT)(DG)(DT)(DA)(DG)(DA)(DT)(DT)(DG)(DA)(DG)(DT)(DC)(DG)(DC)(DT) non-target dsDNA Pseudomonas aeruginosa LEVO (DA)(DG)(DC)(DG)(DA)(DC)(DT)(DC)(DA)(DA)(DT)(DC)(DT)(DA)(DC)(DA)(DA)(DA)(DA)(DT) (DG)(DA)(DG)(DC)(DA)(DA)(DA)(DT)(DC)(DA)(DC)(DT)(DG)(DT)(DT)(DG)(DG)(DC)(DA)(DA) (DG)(DC)(DC)(DA)(DG)(DG)(DA)(DT)(DC)(DT)(DG)(DA)(DA)(DC)(DA)(DA)(DT)(DA)(DC)(DC) (DG)(DT)(DC)(DT)(DT)(DA)(DA)(DC)(DT)(DC)(DG)(DA)(DG)(DC)(DT)(DG)(DC) singleParticle particle 7.5

unspecified

ETHANE

FEI TALOS ARCTICA FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 200 100.0 2.7 0.8 1.2 36000.0 NITROGEN GATAN K2 SUMMIT (4k x 4k) COUNTING 6472 11.5 66.0 1 1049173 C1 4.2 FSC 0.143 CUT-OFF RELION 3.1 152066 MAXIMUM LIKELIHOOD MAXIMUM LIKELIHOOD